SIPC Sipp Industries Announces Locations Carrying Major

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
856
SIPC Sipp Industries Announces Locations Carrying Major Hemp H-IPA More Than Double In December
GlobeNewswire•December 13, 2018
Major Hemp H-IPA Now Available in Over 50 Establishments as Demand Intensifies Throughout Illinois

COSTA MESA, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Sipp Industries, Inc. (SIPC), a multifaceted corporation specializing in technology, manufacturing and distribution of commercial and consumer products, announces Major Hemp H-IPA is now being carried in 55 locations throughout the state of Illinois. The company reports that over the past few weeks, local establishments, pubs and liquor stores have expressed a significantly increased interest in selling the premium hemp-infused craft beer.

Sipp Industries’ distributor Wein-Bauer continues to make inroads with key customers and has now placed Major Hemp H-IPA in more than 20 store locations of Binny’s Beverage Depot, the largest beer and liquor chain in the state of Illinois. In addition, the company is in final discussions with two key national convenience and grocery store chains that have verbally committed to carrying Major Hemp H-IPA. After the completion of final approvals, Major Hemp H-IPA is expected to be placed into initial locations over the coming weeks.

President Ted Jorgensen of wholly-owned subsidiary, Major Hemp stated, “Our hemp beer has exceeded expectations, which is a testament to the brewing and distribution partners we have selected. The next run of Major Hemp H-IPA, expected be completed by the end of the year, will be considerably larger in order to enable timely fulfillment of our current retailers as well as new customers.”

In order to ramp up production, distribution and dissemination of its Hemp beers, Sipp Industries is in the process of submitting multiple recipe and Certificate of Label Approvals (COLA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB). Once approved, this will permit the company to sell Major Hemp H-IPA in Colorado, and its first hemp-infused craft brew, Major Hemp Brown Ale, in both Colorado and Illinois. With two craft beers selling in two states, this expansion will allow for a potential quadrupling of sales within the next few months.

Recent events in Congress have paved the way for the national legalization of Hemp and all of its constituents, including cannabidiol (CBD). Following an 87-13 vote on Tuesday in the Senate, a 369-47 vote on Wednesday afternoon in the House of Representatives clinched the passage of the $867 billion “Farm Bill” through both chambers. Tucked inside the 807-page bill is Senate Majority Leader Mitch McConnell’s Hemp Farming Act of 2018, which removes Hemp and Hemp-derived CBD from the Schedule of Controlled Substances. This federal legalization of Hemp and Hemp-CBD is expected to radically transform the scope of the Hemp industry in the United States. Brightfield Group, one of the preeminent analytical forecasters in the cannabis space, is projecting the Hemp-CBD market to grow from $600 million in 2018 to $22 billion in 2022. Hemp-infused and CBD-infused beverages are anticipated to be one of the most rapidly growing divisions within this new American Hemp economy.

Chief Executive Officer of Sipp Industries, Syman Vong, concluded, “We have been inundated with demand for Major Hemp H-IPA since it was launched in November. With the recent passage of federal hemp legalization through Congress, we anticipate that requests for our Hemp-infused IPA will multiply at a greater rate and opportunities for the national expansion of our company will open up, given the increased acceptance and decreased stigma surrounding hemp-infused alcoholic beverages. In addition, we are now beginning to receive inquiries about CBD-infused versions of Major Hemp beer. So the past several weeks have been a really fantastic period of time for our company. Utilizing our successful business model of hemp beer development, production and distribution, we will continue to procure additional breweries and distributors in other states, taking the Major Hemp brand of Hemp-infused craft beer into different regions of the country, propelling our company’s growth throughout 2019 and beyond.”

About Sipp Industries, Inc.

Sipp Industries is a multifaceted corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. Through its wholly owned subsidiary, Major Hemp, the Company provides hemp beer, high quality and competitively priced hemp-based products, bulk hemp, CBD supply, co-packing and private labeling services.

Website: http://www.sippindustries.com
Facebook: https://www.facebook.com/SippIndustries
Twitter: @SippIndustries

Forward Looking Statements:

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team.

Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management’s plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management’s control.

Contact:

Ted Jorgensen
Major Hemp President
Sipp Industries, Inc.
Investor Relations
ir@sippindustries.com
949.220.0435

Sipp Industries Inc. (SIPC) Stock Research Links

SIPC Board Company Profile Buy Rating Time & Sales News Filings Financials
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.

1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.

4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 6

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 6

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading

Top 5 Most Recently Viewed Articles

Credicorp Ltd. Prepares for Upcoming Earnings Announcement

Updated Category News Views 163

Credicorp Ltd. Earnings Release Overview Credicorp Ltd. is set to unveil its financial performance for the third quarter. The eagerly anticipated report will be published on a designated date following market closure, marking a significant moment for investors and stakeholders. Essential Earnings Call Details The live webcast and conference call, where executives will...

Continue Reading
Class Action Lawsuit Seeks Justice for CTO Realty Investors

Updated Category News Views 114

Class Action Lawsuit Against CTO Realty Growth, Inc. Recently, a significant class action lawsuit was filed targeting CTO Realty Growth, Inc. (CTO). The allegations center around the claim that the company misled shareholders regarding the sustainability of its dividends, which were purportedly more fragile than previously conveyed. Furthermore, the lawsuit highlights...

Continue Reading
Remarkable Journey of Conjoined Twin Boys at CHOP Hospital

Updated Category News Views 278

Remarkable Journey of Conjoined Twin Boys at CHOP Hospital Amari and Javar Ruffin, who were born conjoined, are an inspiring example of medical advancement. This case represents Children's Hospital of Philadelphia's 32nd success in separating conjoined twins. Separation Process and Surgical Team After nearly a year at Children's Hospital of Philadelphia (CHOP), Amari and...

Continue Reading
Ternium's Q4 Earnings Miss: What's Next for TX Investors?

Updated Category News Views 128

Ternium (NYSE:TX) dropped its Q4 earnings bombshell on February 18, 2026, and let's be real: it wasn't pretty. The company reported an EPS of $0.62—down a staggering 19.48% from estimates that had analysts betting on $0.77. That’s not just a miss; it’s like overshooting the target by a mile in the middle of a game-winning drive. Revenue Plunge: A Red Flag or Just...

Continue Reading
Revolutionary Breakthrough: FDA Approves Itvisma for SMA Treatment

Updated Category News Views 435

FDA Approves Itvisma for Spinal Muscular Atrophy Treatment In a remarkable development, the FDA has approved Itvisma (onasemnogene abeparvovec-brve), marking a significant milestone in the treatment of spinal muscular atrophy (SMA). This breakthrough therapy is the only gene replacement option for individuals aged two years and above, including children, teens, and adults...

Continue Reading